A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

NCT04775485 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Low-grade Glioma
Advanced Solid Tumor

Interventions

DRUG: Tovorafenib

Sponsor

Day One Biopharmaceuticals, Inc.

Collaborators

[object Object]